Yet, despite this accumulating evidence, the determinants that govern this dualistic behavior remain elusive—an enigma whose resolution is essential for determining whether SIRT7 can be effectively targeted as a tailored, innovative strategy for cancer therapy. The gene discussed is SIRT7; the disease is cancer.